Roche Holding AG logo

Roche Holding AG (RHO1)

Market Open
11 Aug, 06:08
XFRA XFRA
8. 50
-0.4
-4.4944%
4.32B Market Cap
17.54 P/E Ratio
10.85% Div Yield
500 Volume
0 Eps
8.9
Previous Close
Add Transaction
Day Range
8.5 8.5
Year Range
5.3 8.9
Want to track RHO1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

RHO1 trading today lower at €8.5, a decrease of -4.4944% from yesterday's close, completing a monthly increase of 11.8421% or €0.9. Over the past 12 months, RHO1 stock gained 18.8811%.
RHO1 pays dividends to its shareholders, with the most recent payment made on Sep 25, 2025.
The stock of the company had never split.
The company's stock is traded on one exchange.

RHO1 Chart

People also search for

HLE
HELLA GmbH & Co. KGaA
71.1
-1.25%
Eli Lilly and Company Canadian Depositary Receipt
8.4
+11.2583%
UnitedHealth Group Incorporated Canadian Depositary Receipt
6.95
+0.7246%
G0F
Grifols S.A. Sponsored ADR
4.76
0%
BUW
Bio-Rad Laboratories Inc.
250
0%

Roche Holding AG (RHO1) FAQ

What is the stock price today?

The current price is €8.50.

On which exchange is it traded?

Roche Holding AG is listed on XFRA.

What is its stock symbol?

The ticker symbol is RHO1.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 10.85%.

What is its market cap?

As of today, the market cap is 4.32B.

Has Roche Holding AG ever had a stock split?

No, there has never been a stock split.

Roche Holding AG Profile

Pharmaceuticals Industry
Healthcare Sector
Thomas Schinecker CEO
XFRA Exchange
- ISIN
CH Country
103,249 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Roche Holding AG is a global leader in healthcare, with a strong focus on pharmaceuticals and diagnostics. The company has a presence across Europe, North America, Latin America, Asia, Africa, Australia, and Oceania, showcasing a truly international footprint. Founded in 1896, Roche has a long-standing history of innovation and dedication to improving health outcomes. Based in Basel, Switzerland, this esteemed company has been at the forefront of developing and providing solutions to some of the most pressing health challenges faced around the world.

Products and Services

Roche Holding AG offers a broad portfolio of products and services, catering to a wide range of therapeutic areas and diagnostic needs:

  • Pharmaceutical Products

    These include a variety of medications aimed at treating conditions in therapeutic areas such as anemia, various types of blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune diseases, neurological disorders, ophthalmology, respiratory disorders, and transplantation. Roche is also actively developing new pharmaceutical products to address unmet medical needs in these and other areas.

  • In Vitro Diagnostic Tests

    Roche provides a comprehensive range of diagnostic tests for the detection of diseases like cancer, diabetes, Covid-19, hepatitis, human papillomavirus (HPV), among others. These diagnostic tools are essential in the early detection, diagnosis, and monitoring of diseases, leading to better patient outcomes.

  • Diagnostic Instruments

    The company also offers advanced diagnostic instruments used by laboratories, hospitals, and healthcare providers globally. These instruments are crucial for conducting the in vitro diagnostic tests, ensuring accuracy and efficiency in diagnostics.

  • Digital Health Solutions

    Understanding the increasing role of technology in healthcare, Roche is also involved in offering digital health solutions. These innovative technologies aim to improve patient care, enhance diagnostic and therapeutic processes, and enable healthcare providers to deliver more personalized and efficient care.

Contact Information

Address: Konzern Hauptsitz
Phone: 41 61 688 11 11